Literature DB >> 23243200

The body of evidence for advanced technology in radiation oncology.

Justin E Bekelman, Stephen M Hahn.   

Abstract

Mesh：

Year:  2012        PMID： 23243200      PMCID： PMC3536643          DOI： 10.1093/jnci/djs508

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Methodologic challenges to studying patient safety and comparative effectiveness.

Authors:  Brian L Strom
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

2.  Essential elements of a technology and outcomes assessment initiative.

Authors:  Ezekiel J Emanuel; Victor R Fuchs; Alan M Garber
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

Review 3.  Choosing between randomised and non-randomised studies: a systematic review.

Authors:  A Britton; M McKee; N Black; K McPherson; C Sanderson; C Bain
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

4.  Implications of comparative effectiveness research for radiation oncology.

Authors:  Justin E Bekelman; Anand Shah; Stephen M Hahn
Journal:  Pract Radiat Oncol       Date:  2011-04-08

5.  Late gastrointestinal toxicities following radiation therapy for prostate cancer.

Authors:  Sung Kim; Shunhua Shen; Dirk F Moore; Weichung Shih; Yong Lin; Hui Li; Matthew Dolan; Yu-Hsuan Shao; Grace L Lu-Yao
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

6.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Authors:  Nathan C Sheets; Gregg H Goldin; Anne-Marie Meyer; Yang Wu; YunKyung Chang; Til Stürmer; Jordan A Holmes; Bryce B Reeve; Paul A Godley; William R Carpenter; Ronald C Chen
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

7.  Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

Authors:  James B Yu; Pamela R Soulos; Jeph Herrin; Laura D Cramer; Arnold L Potosky; Kenneth B Roberts; Cary P Gross
Journal:  J Natl Cancer Inst       Date:  2012-12-14       Impact factor: 13.506

8.  Compensating for heterogeneities in proton radiation therapy.

Authors:  M Urie; M Goitein; M Wagner
Journal:  Phys Med Biol       Date:  1984-05       Impact factor: 3.609
  8 in total
  4 in total

Review 1.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

2.  Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

Authors:  Shervin M Shirvani; Jing Jiang; Daniel R Gomez; Joe Y Chang; Thomas A Buchholz; Benjamin D Smith
Journal:  Lung Cancer       Date:  2013-08-21       Impact factor: 5.705

3.  Implementation of intensity modulated radiotherapy for prostate cancer in a private radiotherapy service in Mexico.

Authors:  María Adela Poitevin-Chacón; Gabriel Reséndiz González; Adriana Alvarado Zermeño; Jesús Manuel Flores Castro; Christian Haydée Flores Balcázar; Samuel Rosales Pérez; Miguel Angel Pérez Pastenes; Alejandro Rodríguez Laguna; Patricio Vázquez Fernández; Alejandro Calvo Fernández; Jorge Bastida Ventura
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-12

4.  R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology.

Authors:  Helena M Verkooijen; Linda G W Kerkmeijer; Clifton D Fuller; Robbert Huddart; Corinne Faivre-Finn; Marcel Verheij; Stella Mook; Arjun Sahgal; Emma Hall; Chris Schultz
Journal:  Front Oncol       Date:  2017-04-03       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.